INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $115,000 | -29.0% | 2,228 | 0.0% | 0.01% | -28.6% |
Q1 2022 | $162,000 | -43.6% | 2,228 | -8.2% | 0.01% | -30.0% |
Q4 2021 | $287,000 | -36.9% | 2,426 | -28.5% | 0.01% | -28.6% |
Q3 2021 | $455,000 | -69.8% | 3,394 | -63.6% | 0.01% | -61.1% |
Q2 2021 | $1,508,000 | +37.5% | 9,313 | -31.9% | 0.04% | +38.5% |
Q1 2021 | $1,097,000 | -21.5% | 13,670 | -46.8% | 0.03% | -13.3% |
Q4 2020 | $1,397,000 | +154.5% | 25,681 | -6.9% | 0.03% | +150.0% |
Q3 2020 | $549,000 | -11.3% | 27,598 | -6.3% | 0.01% | -14.3% |
Q2 2020 | $619,000 | +57.9% | 29,447 | -8.2% | 0.01% | +55.6% |
Q1 2020 | $392,000 | -16.8% | 32,076 | 0.0% | 0.01% | -18.2% |
Q4 2019 | $471,000 | +46.7% | 32,076 | +33.5% | 0.01% | +57.1% |
Q3 2019 | $321,000 | – | 24,026 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |